Jump to content

18914687. PERTUZUMAB VARIANTS AND EVALUATION THEREOF (Genentech, Inc.)

From WikiPatents
Revision as of 05:15, 15 March 2025 by Unknown user (talk) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

Organization Name

Genentech, Inc.

Inventor(s)

Lynn A. Gennaro of San Mateo CA (US)

Yung-Hsiang Kao of San Mateo CA (US)

Yonghua Zhang of Foster City CA (US)

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

This abstract first appeared for US patent application 18914687 titled 'PERTUZUMAB VARIANTS AND EVALUATION THEREOF

Original Abstract Submitted

The present application discloses variants of Pertuzumab. In particular, it discloses: an unpaired cysteine variant comprising Cys23/Cys88 unpaired cysteines in one or both variable light domains of Pertuzumab, an afucosylated variant of Pertuzumab, a low-molecular-weight-species (LMWS) of Pertuzumab, and a high-molecular-weight-species (HMWS) or Pertuzumab. The application further discloses the isolated variants, compositions, pharmaceutical compositions, and articles of manufacture comprising the variants, as well as methods of making and characterizing the variants and compositions thereof.

(Ad) Transform your business with AI in minutes, not months

Custom AI strategy tailored to your specific industry needs
Step-by-step implementation with measurable ROI
5-minute setup that requires zero technical skills
Get your AI playbook

Trusted by 1,000+ companies worldwide

Cookies help us deliver our services. By using our services, you agree to our use of cookies.